A distinct glioma stem cell population was identified, characterized by high proliferative potential and an enrichment of E2F1, E2F2, E2F7, and BRCA1 regulons, with implications for tumor growth and patient outcomes. This evidence concerns the gene E2F7 and central nervous system cancer.